Treatment of Chronic Fatigue Syndrome and Fibromyalgia with D-Ribose– An Open-label, Multicenter Study

All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Treatment of Chronic Fatigue Syndrome and Fibromyalgia with D-Ribose– An Open-label, Multicenter Study

Jacob Teitelbaum, * Open Modal , 1 Janelle Jandrain2 Ryan McGrew3
Authors Info & Affiliations
The Open Pain Journal • 27 Jun 2012 • RESEARCH ARTICLE • DOI: 10.2174/1876386301205010032

Abstract

Objectives:

Chronic Fatigue Syndrome and Fibromyalgia (CFS/FMS) are debilitating syndromes affecting ~2- 4% of the population. Although they are heterogeneous conditions associated with many triggers, they appear to have the common pathology of being associated with impaired energy metabolism.

As D-ribose has been shown to increase cellular energy synthesis, and was shown to significantly improve clinical outcomes in CFS/FMS in an earlier study, we hypothesized that giving D-ribose would improve function in CFS/FMS patients.

Design, Location, and Subjects:

An open-label, unblinded study in which 53 US clinics enrolled 257 patients who had been given a diagnosis of CFS/FMS by a health practitioner.

Interventions:

All subjects were given D-ribose (Corvalen™), a naturally occurring pentose carbohydrate, 5-g TID for 3 weeks.

Outcome measures:

Keywords: Fibromyalgia, Chronic Fatigue Syndrome, Energy Levels, D-Ribose, Pain, pain Relief.